Literature DB >> 21396846

The predominance of benign histology in small testicular masses.

Yaniv Shilo1, Amnon Zisman, Arie Lindner, Orit Raz, Simon Strauss, Yoram I Siegel, Michael Segal, Judith Sandbank, Dan Leibovici.   

Abstract

OBJECTIVES: To evaluate the concordance between testicular tumor size and benign histology in order to identify a cut-off size, below which the rate of benign lesions would be highest. METHODS AND MATERIALS: During the years 1995-2008, we performed 131 consecutive testicular operations for testicular tumors. Ten of these were testicular preserving surgery, whereas the other 121 patients had radical orchiectomy. We searched for the rate of benign lesions in the following 3 groups of tumor diameter: 10 mm or less, 11-20 mm, and greater than 20 mm. ROC analysis was used to find the optimal size cut-off below which the rate of benign lesions would be highest.
RESULTS: Benign lesions were found in 11 patients (8%), including epidermoid cyst (n = 4), Leydig cell tumor (n = 3), fibrosis (n = 1), adenomatoid tumor (n = 2), and 1 patient with a simple cyst. Small tumor size strongly correlated with benign histology. The mean diameter of benign vs. malignant lesions was 15 mm and 41 mm, respectively (P < 0.05). The rate of benign lesions in tumors with a diameter of 10 mm or less, 11-20 mm and greater than 20 mm was 50%, 17%, and 2%, respectively. Receiver Operating characteristic (ROC) analysis with 87% sensitivity and 83% specificity revealed a cut-off value of 18.5 mm tumor diameter below which the proportion of benign lesions was 38.5% compared with 2% above it (P < 0.05).
CONCLUSIONS: While benign lesions comprise only 8% of all testicular tumors, their proportion among small lesions is much higher. With a size cut-off of 18.5 mm, 38.5% of smaller lesions are benign. These findings support consideration of testicular exploration for small testicular lesions aiming at preservation rather than predetermined radical orchiectomy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21396846     DOI: 10.1016/j.urolonc.2010.08.022

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  9 in total

Review 1.  Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia in situ.

Authors:  Pia Paffenholz; David Pfister; Axel Heidenreich
Journal:  Transl Androl Urol       Date:  2020-01

2.  A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome.

Authors:  Lindsay M Yuh; Primo N Lara; Rebecca M Wagenaar; Christopher P Evans; Marc A Dall'era; Rosemary Cress; Stanley A Yap
Journal:  Can Urol Assoc J       Date:  2017-09       Impact factor: 1.862

3.  How to manage testicular capillary haemangioma: Editorial Comment on: W. Białek, S. Rudzki, L. Wroniecki: Capillary hemangioma of the testis. A case report of a rare benign tumor.

Authors:  Tomasz Gołąbek; Piotr L Chłosta
Journal:  J Ultrason       Date:  2016-03-29

4.  Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.

Authors:  Carlotta Pozza; Riccardo Pofi; Marta Tenuta; Maria Grazia Tarsitano; Emilia Sbardella; Giorgio Fattorini; Vito Cantisani; Andrea Lenzi; Andrea M Isidori; Daniele Gianfrilli
Journal:  Hum Reprod       Date:  2019-08-01       Impact factor: 6.918

5.  Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.

Authors:  Manolis Pratsinis; Christian Fankhauser; Katerina Pratsinis; Jörg Beyer; Emanuel Bührer; Richard Cathomas; Natalie Fischer; Thomas Hermanns; Anita Hirschi-Blickenstorfer; Jörn Kamradt; Luis Alex Kluth; Deborah Zihler; Walter Mingrone; Beat Müller; Tim Nestler; Sacha I Rothschild; Bettina Seifert; Arnoud J Templeton; Angelika Terbuch; Mark-Peter Ufen; Regina Woelky; Silke Gillessen; Christian Rothermundt
Journal:  Eur Urol Open Sci       Date:  2022-04-26

6.  The Diagnostic Value of the Added MR Imaging of the Scrotum in the Preoperative Workup of Sonographically Indeterminate Testicular Lesions-A Retrospective Multicenter Analysis.

Authors:  Susanne Deininger; Lukas Lusuardi; Maximilian Pallauf; Stefan Hecht; Rosemarie Forstner; Matthias Meissnitzer; Florian A Distler; Eva Erne; Sebastian Graf; Sebastian Lenart; Juliane Putz; Christian Deininger; Peter Törzsök
Journal:  Cancers (Basel)       Date:  2022-07-23       Impact factor: 6.575

Review 7.  Prevalence and Management of Incidental Testicular Masses-A Systematic Review.

Authors:  Daniel Henriques; Anabela Mota Pinto; Helena Donato; Ricardo Leão
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

8.  The value of testicular ultrasound in the prediction of the type and size of testicular tumors.

Authors:  Abraham Shtricker; David Silver; Elias Sorin; Letizia Schreiber; Nachum Katlowitz; Alexander Tsivian; Kalman Katlowitz; Shalva Benjamin; Abraham Ami Sidi
Journal:  Int Braz J Urol       Date:  2015 Jul-Aug       Impact factor: 1.541

9.  The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.

Authors:  Gang Song; Geng-Yan Xiong; Yu Fan; Cong Huang; Yong-Ming Kang; Guang-Jie Ji; Jin-Chao Chen; Zhong-Cheng Xin; Li-Qun Zhou
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.